Sentiment Report: Biogen Idec Inc (NASDAQ:BIIB)

Xavier Trudeau
Juin 3, 2017

Bienville Capital Management LLC now owns 861 shares of the biotechnology company's stock valued at $244,000 after buying an additional 6 shares during the period.

Biogen Inc is a biopharmaceutical company. It has underperformed by 11.76% the S&P500. Sentinel Asset Mngmt reported 0.3% stake. Moreover, Mai Cap Mngmt has 0.09% invested in Biogen Inc (NASDAQ:BIIB) for 4,166 shares. The Gmt Capital Corp holds 197,900 shares with $56.12M value, up from 193,390 last quarter.

More important recent Ring Energy Inc (NYSEMKT:REI) news were published by: which released: "Ring Energy: 576% Cash Flow Explosion" on May 12, 2017, also published article titled: "Ring Energy: When The Old Ways No Longer Make Money, Change And Print Money", published: "Ring Energy: Sell Friday's Rally And Buy Callon Petroleum" on April 03, 2017. The stock increased 1.05% or $0.69 during the last trading session, reaching $66.71. About 665,763 shares traded. It has underperformed by 6.07% the S&P500.

Last time, the company shocked Wall Street by reporting EPS of $5.20, smashing the consensus of $4.97 per share. The stock rose 0.25% or $0.62 reaching $253 per share. BIIB's profit will be $1.03B for 13.06 P/E if the $4.83 EPS becomes a reality.

Since January 1, 0001, it had 2 insider buys, and 4 selling transactions for $4.56 million activity. Beacon Trust Co. now owns 1,135 shares of the biotechnology company's stock valued at $328,000 after buying an additional 6 shares during the last quarter. Signaturefd Ltd invested in 973 shares. 5,450 shares were sold by PANGIA ROBERT W, worth $1.61M.

05/24/2017 - Biogen Idec Inc. had its " rating reiterated by analysts at Sanford C. Bernstein. Therefore 60% are positive. BIIB was included in 40 notes of analysts from July 23, 2015. The original version of this piece of content can be accessed at Wunderlich maintained Ring Energy Inc (NYSEMKT:REI) on Thursday, May 12 with "Buy" rating. The stock of Biogen Inc (NASDAQ:BIIB) earned "Neutral" rating by Credit Suisse on Wednesday, January 20. Piper Jaffray upgraded the stock to "Overweight" rating in Thursday, November 5 report. Citigroup upgraded Biogen Inc (NASDAQ:BIIB) on Tuesday, February 7 to "Buy" rating. Mizuho restated a "sell" rating on shares of Biogen in a report on Monday, February 6th.

04/13/2017 - Biogen Idec Inc. had its "neutral" rating reiterated by analysts at Robert W. Baird. Morgan Stanley downgraded it to "Equal-Weight" rating and $305 target in Thursday, March 16 report. The firm has "Hold" rating given on Friday, July 22 by Gabelli.

Investors sentiment decreased to 0.92 in Q4 2016. The company's stock has a normal trading capacity of 1.56M shares while the relative volume is 0.99. The funds in our partner's database now hold: 183.23 million shares, down from 186.04 million shares in 2016Q3. 741 were accumulated by Macguire Cheswick Tuttle Inv Counsel Ltd Liability. State Street invested 0% in TearLab Corp (NASDAQ:TEAR).

By historical standards, Biogen Inc. remains a cheap stock. Renaissance Lc has 110,056 shares for 1.26% of their portfolio. Bedrijfstakpensioenfonds Voor De Media Pno has invested 1.5% in Biogen Inc (NASDAQ:BIIB). Eton Park Capital Management Lp acquired 336,000 shares as Biogen Inc (Call) (BIIB)'s stock declined 13.45%. OUT's SI was 1.88M shares in June as released by FINRA. The company is expected to report EPS as high as $5.89 and as low as $3.78 per share.

Shares of Biogen (NASDAQ BIIB) opened at 252.38 on Wednesday. Retirement Of Alabama holds 147,841 shares or 0.24% of its portfolio. The company was upgraded on Wednesday, March 9 by Feltl & Co. Wedge Cap Mgmt L Ltd Partnership Nc owns 182,558 shares or 0.5% of their USA portfolio. Pacific Ridge Capital Limited Liability reported 125,765 shares or 1.51% of all its holdings. Telefonica Brasil Sa was raised too.

Since February 28, 2017, it had 0 insider buys, and 8 insider sales for $19.23 million activity. Its down 55.22% from 67,000 shares previously. The shares were sold at an average price of $291.55, for a total transaction of $2,883,721.05. The shares were sold at an average price of $290.00, for a total transaction of $2,868,680.00. The insider Clancy Paul J sold $2.88 million.

On 4/27/2017 Alexander J. Denner, Director, bought 73,858 with an average share price of $278.50 per share and the total transaction amounting to $20,569,453.00.

Among 5 analysts covering Biotest (ETR:BIO), 4 have Buy rating, 0 Sell and 1 Hold. Therefore 39% are positive. Freescale Semi had 4 analyst reports since July 27, 2015 according to SRatingsIntel. The rating was initiated by Wedbush with "Neutral" on Friday, July 22. On Tuesday, September 1 the stock rating was initiated by Raymond James with "Strong-Buy".

03/01/2017 - Instinet began new coverage on Biogen Idec Inc. giving the company a " rating.

01/24/2017 - Biogen Idec Inc. had its " rating reiterated by analysts at Jefferies. Equinet upgraded it to "Buy" rating and €18 target in Tuesday, June 21 report. They now have a Dollars 442 price target on the stock. The firm has "Buy" rating given on Friday, October 23 by UBS. The firm has "Buy" rating given on Tuesday, August 11 by TheStreet.

Investors sentiment decreased to 1.33 in Q4 2016. Its down 0.08, from 1 in 2016Q3. It fall, as 86 investors sold ABBV shares while 555 reduced holdings. 14 funds opened positions while 30 raised stakes. Eqis Cap Management invested 0.07% in AbbVie Inc (NYSE:ABBV). Loring Wolcott Coolidge Fiduciary Advsrs Limited Liability Partnership Ma stated it has 0.05% in Biogen Inc (NASDAQ:BIIB). Moody Commercial Bank Tru Division reported 13,838 shares or 0.04% of all its holdings. S Squared Llc stated it has 48,498 shares. Zweig owns 900 shares for 0.02% of their portfolio. Hudock Group Limited Com owns 100 shares. Exane Derivatives invested 0% in AbbVie Inc (NYSE:ABBV). Girard Partners accumulated 887 shares. Ellington Mgmt Grp Lc invested in 2,200 shares. Airain has 277,550 shares for 1.4% of their portfolio. Highvista Strategies Ltd holds 52,109 shares. Andra Ap holds 16,700 shares. Wisconsin-based Northwestern Mutual Wealth Mgmt has invested 0.07% in AbbVie Inc (NYSE:ABBV).

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

D'autres rapports CampDesrEcrues

Discuter de cet article